IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 110

Article Submitted : 16365

Article Published : 7180

Total Authors : 19282

Total Reviewer : 691

Total Countries : 126

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: CRISPR-Cas9 and its Role in Gene Therapy
Authors Name: Shriya Jogadhenu
Download E-Certificate: Download
Author Reg. ID:
IJRTI_190377
Published Paper Id: IJRTI2410027
Published In: Volume 9 Issue 10, October-2024
DOI:
Abstract: This paper explores the revolutionary technology of CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats associated with Cas9 endonuclease) and its significant role in the field of gene therapy. The advent of CRISPR-Cas9 has opened new avenues for precise genomic editing, offering distinct advantages over traditional gene therapy methods, including enhanced specificity, efficiency, and ease of use. This research aims to provide a comprehensive overview of the advantages, limitations, clinical applications and potential solutions for future research in CRISPR-Cas9 applications. We will discuss the current landscape of clinical trials utilizing CRISPR-Cas9 for various genetic disorders and diseases, highlighting successful implementations in conditions such as sickle cell anemia, muscular dystrophy, and certain types of cancer. Furthermore, this paper will delve into the therapeutic purposes, medications and mediations that CRISPR-Cas9 can potentially offer, addressing its transformative impact on the treatment of genetic diseases. The findings will underline both the promise and the ethical considerations surrounding this technology, paving the way for future advancements in gene therapy.
Keywords: CRISPR-Cas9, gene therapy, clinical application, disorders, conditions
Cite Article: "CRISPR-Cas9 and its Role in Gene Therapy", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.9, Issue 10, page no.258 - 265, October-2024, Available :http://www.ijrti.org/papers/IJRTI2410027.pdf
Downloads: 000204975
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2410027
Registration ID:190377
Published In: Volume 9 Issue 10, October-2024
DOI (Digital Object Identifier):
Page No: 258 - 265
Country: Hyderabad, Telangana, India
Research Area: Biological Science
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2410027
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2410027
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner